Indonesia vs Myanmar: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Indonesia
- Myanmar
How they compare
Indonesia currently reports 51.6% against 51.3% in Myanmar, a difference of 0.3%.
Across all 5 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 47th and Myanmar ranks 48th of 113 countries.
Indonesia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 50.9% | 20.9% | 30.0% | Indonesia |
| 2000s | 54.6% | 33.6% | 20.9% | Indonesia |
| 2010s | 58.2% | 51.3% | 6.9% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Indonesia or Myanmar?
- Indonesia, at 51.6% against 51.3% in Myanmar as of 2023.
- What is the difference in contraceptive prevalence, any modern method between Indonesia and Myanmar?
- 0.3%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Myanmar?
- 5 years are reported by both, from 1991 to 2016.
- How do Indonesia and Myanmar rank globally for contraceptive prevalence, any modern method?
- Indonesia ranks 47th and Myanmar ranks 48th of 113 countries.
- Where does this data come from?
- Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.